0 items USD 0.00Search
Your search for "gbi research diabetes therapeutics market india 2018 rapid uptake dpp iv inhibitors glp 1 agonists" gave back 820030 results.
The global Antidiabetic Drug market size was valued at US$ 43640 million in 2023. With growing demand in downstream market, the Antidiabetic Drug is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Type 2 Diabetes market size was valued at US$ 63700 million in 2023. With growing demand in downstream market, the Type 2 Diabetes is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Medication for Diabetes market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period...
Catalog:
GIR
March 2024
Price: USD 4,480.00
Medication for diabetes is a broad term that refers to any drug or treatment that helps people with diabetes manage their blood sugar levels. Blood...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
This Report focus on medications for type 2 diabetes. People with type 2 diabetes are often given medications including insulin to help manage their...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Medication for Diabetes market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The Dipeptidyl Peptidase IV (DPP-IV) inhibitors market refers to the industry that focuses on the production and distribution of medications known as...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Incretin-Based Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs. Also known as gliptins, they are usually prescribed for...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Type 2 Diabetes Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
